Conference abstract
Conference abstractPublished 26 Oct 2018
Precision Medicine: We the Consumers
R&D Ribitzky
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The Total Addressable Market (TAM) for Precision Medicine is on a trajectory of 10%+ CAGR to surpass $100B around 2025 as patient demand is on the rise, the cost of human genome sequencing continues to go down, AI happens deep inside the chip, blockchain is heading everywhere, and medical devices are just about to switch channel to IoT chat. Yet, it still takes 10+ years for basic science discovery to make a difference in the life of the first consumer it was intended for. In this session, we will re-examine the ever-elusive Precision Medicine Paradox, white space R&D, healthcare in disruption, and We the Consumers.
Subjects
General & Internal MedicineAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract
Precision medicine: We the consumers
Research article · 10 Mar 2023
Impact of Bureau of Pharma PSU's India Affordable Cost Medicine Scheme on Economic Consumers
Research article · 21 Mar 2017
Self‑Reported Use of Complementary and Alternative Medicine among the Health Care Consumers at a Tertiary Care Center in Ajman, United Arab Emirates
Research article · 2013
Selfâ??Reported Use of Complementary and Alternative Medicine among the Health Care Consumers at a Tertiary Care Center in Ajman, United Arab Emirates
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectGeneral & Internal Medicine
- BylineArticles whose byline prints “Ron Ribitzky”
